Mechanisms of hepatic transport of cyclosporin a: An explanation for its cholestatic action?

Yale Journal of Biology and Medicine

Volumn 70, Issue 4, 1997, Pages 379-390

  Fricker, Gert ^a   Fahr, Alfred ^b  

^a Inst F Pharmazeut Technol B   (Germany)

^b Inst F Pharmazeut Technol B   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BILE ACID; BILE SALT; CALCIUM ION; CYCLOSPORIN A; SODIUM ION; TAUROCHOLIC ACID;

ANIMAL CELL; ANISOTROPY; CHOLESTASIS; CONCENTRATION RESPONSE; CONFERENCE PAPER; CONTROLLED STUDY; DIFFUSION; DOSE RESPONSE; DRUG TRANSPORT; FLUORESCENCE; HOMEOSTASIS; INTRAHEPATIC BILE DUCT; ION CURRENT; LIVER; LIVER CELL; MALE; MEMBRANE PERMEABILITY; MEMBRANE VESICLE; NONHUMAN; PARTITION COEFFICIENT; PHOSPHOLIPID MEMBRANE; PHOTOAFFINITY LABELING; RAT;

AFFINITY LABELS; ANIMALS; BILE CANALICULI; BIOLOGICAL TRANSPORT, ACTIVE; CELL MEMBRANE; CHOLESTASIS; CYCLOSPORINE; FLUORESCENCE POLARIZATION; KINETICS; LIPOSOMES; LIVER; MALE; MEMBRANE FLUIDITY; RATS; RATS, WISTAR; TAUROCHOLIC ACID;

EID: 0031393827     PISSN: 00440086     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (41)

1. Borel, J.F., Feurer, C., Gubler, H.U., and Stähelin, H. Biological effects of cyclosporin A: A new antilymphocytic agent. Agents and Actions 6:468-475, 1976.
2. Cohen, D.J., Loertscher, R., Rubin, M., Tilney, N.L., Carpenter, C.B., and Strom, T.B. Cyclosporin: A new immunosuppressive agent for organ transplantation. Ann. Intern. Med. 101:667-682, 1984.
3. Rogers, A.J and Kahan, B.D. Mechanism of action and clinical applications of cyclosporins in organ transplantation. Clin. Allergy Immunol. 4:217-258, 1984.
4. Kahan, B.D. Cyclosporine. New Engl. J. Med. 321:1725-1738, 1989.
5. Mason, J. The pathophysiology of sandimmune (cyclosporine) in man and animals. Pediat. Nephrol. 4:554-574, 1990.
6. Schade, R.R., Guglielmi, A., Van Thiel, D.H., Thomson, M.E., Warty, V., Griffith, B., Sanghvi, A., Bahnson, H., and Hardesty, R. Cholestasis in heart transplant recipients treated with cyclosporine. Transplant. Proc. 25:2757-2760, 1983.
7. Rodger, R.S.C., Turney, J.H., Haines, I., Michael, J., Adu, D., and McMaster, P. Cyclosporine and liver function in renal allograft recipients. Transplant. Proc. 15 (Suppl. 1/2):2754-2756, 1983.
8. Atkinson, K., Biggs, J., Dodds, A., and Concannon, A. Cyclosporine-associated hepatoxicity after allogenic marrow transplantation in man. Differentiation from other causes of post transplant liver disease. Transplant. Proc. 25:2761-2767, 1983.
9. Roman, I.D., Monte, M.J., Gonzalez-Buitrago, J.M., Esteller, A., and Jiménez, R. Inhibition of hepatocytary vesicular transport by cyclosporin A in the rat: Relationship with cholestasis and hyperbilirubinemia. Hepatol. 12:83-91, 1990.
10. Stone, B., Warty, V., Dindzans, V., and Van Thiel, D. The mechanism of cyclosporin-induced cholestasis in the rat. Transplant. Proc. 20:Suppl.3, 841-844, 1988.
11. Dahlback-Sjoberg, H., Bjorkhem, J., and Princen, H.M. Selective inhibition of mitochondrial 27-hydroxylation of bile acid intermediates and 25-hydroxylation of vitamin D3 by cyclosporin A. Biochem. J. 293:203-206, 1993.
12. Ellis, C.N., Gorsulowsky, D.C., Hamilton, T.A., Billings, J.K., Brown, M.D., Headington, J.T., Cooper, K.D., Baadsgaard, O., Duell, E.A., Annesley, T.M., Turcotte, J.G., and Voorhees, J.J. Cyclosporine improves psoriasis in a double blind study. JAMA 256:3110-3116, 1986.
13. Farthing, M.J.G., Clark, M.L., Pendry, A., Sloane, J., and Alexander, P. Nature of the toxicity of cyclosporin A in the rat. Biochem. Pharmacol. 30:3311-3316, 1981 .
14. Ziegler, K. and Frimmer, M. Cyclosporin A and a diaziridine derivative inhibit the hepatocellular uptake of cholate, phalloidin and rifampicin. Biochim. Biophys. Acta 855:136-142, 1986.
15. Moseley, R.H., Johnson, T.R., and Morrissette, J.M. Inhibition of bile acid transport by cyclosporine A in rat liver plasma membrane vesicles. J. Pharmacol. Exp. Ther. 253:974-980, 1990.
16. +-dependent taurocholate uptake in basolateral (sinusoidal) rat liver plasma membrane vesicles. J. Pharmacol. Exp. Ther. 250:301-308, 1987.
17. Berry, M.N. and Friend, D.S. High-yield preparation of isolated liver parenchymal cells. A biochemical and fine structural study. J. Cell Biol. 43:506-520, 1969.
18. Anwer, M.S., Kroker, R., and Hegner, D. Cholic acid uptake into isolated rat hepatocytes. Hoppe-Seyler's Zeitschr. Physiol. Chem. 357:1477-1486, 1976.
19. Schramm, U., Fricker, G., Buscher, H.-P., Gerok, W., and Kurz, G. Fluorescent derivatives of bile salts. III. Uptake of 7β-NBD-NCT into isolated hepatocytes by the transport systems for taurocholate. J. Lipid Res. 34:741-757, 1993.
20. Meier, P.J., Sztul, E.Z., Reuben, A., and Boyer, J.L. Structural and functional polarity of canalicular and basolateral plasma membrane vesicles isolated in high yield from rat liver. J. Cell Biol. 98:991-1000, 1984.
21. Ruetz, S., Fricker, G., Hugentobler, G., Winterhalter, K., Kurz, G., and Meier, P.J. Isolation and characterization of the putative canalicular bile sait transport system of rat liver. J. Biol. Chem. 262:11324-11330, 1987.
22. Hugentobler, G., Fricker, G., Boyer, J.L., and Meier, P.J. Anion transport in basolateral (sinusoidal) liver plasma-membrane vesicles of the little skate (Raja erinacea) Biochem. J. 247:589-595, 1987.
23. MacDonald, R.C., MacDonald, R.I., Menco, B.P.M., Takeshita, K., Subbarao, N.K., and Hu, L.R. Small-volume extrusion apparatus for preparation of large unilamellar vesicles. Biochim. Biophys. Acta 1061:297-303, 1991.
24. Fahr, A. Cyclosporin clinical pharmacokinetics. Clin. Pharmacokin. 24:472-495, 1993.
25. Mason, J. The pathophysiology of Sandimmune (cyclosporine) in man and animals. Pediatr. Nephrol. 4, 686-704, 1990.
26. Azer, S.A. and Stacey, N.H. Effect of cyclosporin A in vivo on cholyltaurine uptake by rat hepatocytes. Biochem. Pharmacol. 42:2053-2057, 1991.
27. 2+-ionophores. Biochim. Biophys. Acta 886:353-360, 1986.
28. Damjanovich, S., Aszalos, A., Mulhern, S., Szöllösi, J., Balazs, M., Tron, L., and Fulwyler, M.J. Cyclosporin A depolarizes human lymphocytes: earliest observed effect on cell metabolism. Eur. J. Immunol. 17:763-768, 1987.
29. Kukongviriyapan, V. and Stacey, N.H. Inhibition of cholyltaurine transport by cyclosporin A in cultured rat hepatocytes. J. Pharmacol. Exp. Ther. 247:685-689, 1988 .
30. Schramm, U., Fricker, G., Wenger, R., and Miller, D.S. P-glycoprotein-mediated secretion of a fluorescent cyclosporin analogue by teleost renal proximal tubules. Am. J. Physiol. 268:F46-F52, 1995.
31. Böhme, M., Buchler, M., Muller, M., and Keppler, D. Differential inhibition by cyclosporins of primary-active ATP-dependent transporters in the hepatocyte canalicular membrane. FEBS-Lett. 333:193-196, 1993.
32. Kadmon, M., Klunemann, C., Böhme, M., Ishikawa, T., Gorgas, K., Otto, G., Herfarth, C., and Keppler, D. Inhibition by cyclosporin A of adenosine triphosphate-dependent transport from the hepatocyte into bile. Gastroenterol. 104:1507-1514, 1993.
33. Thalhammer, T., Stapf, V., Gajdzik, L., and Graf, J. Bile canalicular cationic dye secretion as a model for P-glycoprotein mediated transport. Eur. J. Pharmacol. 270:213-220, 1994.
34. Stapf, V., Thalhammer, T., Huber, R., Felberbauer, F., Gajdzik, L., and Graf, J. Inhibition of rhodamine 123 secretion by cyclosporin A as a model of P-glycoprotein mediated transport in liver. Anticancer Res. 14:581-558, 1994.
35. Boesch, D., Muller, K., Pourtier Manzanedo, A., and Loor, F. Restoration of daunomycin retention in multidrug-resistant P388 cells by submicromolar concentrations of SDZ PSC 833, a non-immunosuppressive cyclosporin derivative. Exp. Cell Res. 196:26-32, 1991.
36. Twentyman, P.R. Cyclosporins as drug resistance modifiers. Biochem. Pharmacol. 43:109-117, 1992.
37. Keller, R.P., Altermatt, H.J., Nooter, K., Poschmann, G., Laissue, J.A., Bollinger, P., and Hiestand, P.C. SDZ PSC 833, a non-immunosuppressive cyclosporine: its potency in overcoming P-glycoprotein-mediated multidrug resistance of murine leukemia. Int. J. Cancer 50:593-597, 1992. .
38. Miller, D., Fricker, G., and Drewe, J. p-Glycoprotein-mediated transport of a fluorescent rapamycin derivative in renal proximal tubules. J. Pharmacol. Exp. Therap. 282, 440-444, 1997.
39. Jette, L., Beaulieu, E., Leclerc, J.M., and Beliveau, R. Cyclosporin A treatment induces overexpression of P-glycoprotein in the kidney and other tissues. Am. J. Physiol. 270:F756-765, 1996.
40. Fricker, G., Drewe, J., Huwyler, J., Gutmann, H., and Beglinger, C. Relevance of p-glycoprotein for the enterai absorption of cyclosporin A. In vitro-in vivo correlation. Brit. J. Pharmacol. 118:1841-1847, 1996.
41. Schinkel, A.H., Wagenaar, E., van Deemter, L., Mol, C.A., and Borst, P. Absence of the mdrla P-Glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A. J. Clin. Invest. 96:1698-1705, 1995.